Company Data
Spruce Biosciences Inc.
Ticker
SPRB
Current Price
$0.06298 4.27%
Market Cap
$2.7M
Price Target
Refer to Report
Volume
53.1K
52wk Range
$0.057 - $0.7689
Overview
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders. The company is developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH).